Concurrent Control of Sodium and Bicarbonate Serum Concentrations Using a Four‐Stream Hemodialysis Fluid Delivery System
This system makes the treatment of profound dysnatremias, metabolic acid-base disorders, and combined dysnatremias and metabolic acid-base disorders feasible. The clinical application of the system demands prior in vitro or ex vivo studies plus fastidious and expert attention to ensure safe and dependable application.
Authors
- Susie Q. Lew (ORCID: https://orcid.org/0000-0002-1618-1024)
- Todd S. Ing (ORCID: https://orcid.org/0000-0002-6804-9260)
- Robert H. Glew (ORCID: https://orcid.org/0000-0003-2453-4771)
- Antonios Helias Tzamaloukas (ORCID: https://orcid.org/0000-0002-7170-3323)
- D.V. Malhotra (ORCID: https://orcid.org/0000-0002-0934-1560)
- Ramin Sam (ORCID: https://orcid.org/0000-0002-4016-6676)
- Raymond E. Garrett
Institutions
- San Francisco General Hospital (US)
- University of New Mexico (US)
- Loyola University Chicago (US)
- George Washington University (US)
- Swedish Medical Center (US)
- Raymond G. Murphy VA Medical Center (US)
- University of Toledo (US)
Publication Details
- Journal
- Hemodialysis International
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1111/hdi.13205
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00